Press release
Atopic Dermatitis Market Growing Demand by Top Key Players like Regeneron Pharmaceuticals, Inc, LEO Pharma A/S, Sanofi, Novartis AG, Bristol-Myers Squibb Company
Atopic Dermatitis Market
Global Atopic Dermatitis Market By Mechanism of Action Type (Antihistamines, Topical corticosteroids, Emollients, Phosphodieterase-4 (PDE-4) inhibitor, Topical antiseptic and Others), Mode of Administration (Injectable, Topical, Oral), Drug Type (Triamcinolone, Clobetasol, Tacrolimus topical, Betamethasone, Pimecrolimus, Fluocinonide, Hydrocortisone, Prednisone, Crisaborole, Fluticasone, Methylprednisolone and Others), Distribution Channel (Mail Order Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores, Retail Pharmacies, Dermatology Clinics), Type, Application, End User, Geography – Industry Trends & Forecast to 2026
Global atopic dermatitis marketin the forecast period of 2019-2026. Growing number of atopic dermatitis population and robust product pipeline are the key drivers for market growth.
Click to Get Global Atopic Dermatitis Market Research Sample PDF Copy Here @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-atopic-dermatitis-market
Some of the major competitors currently working in the atopic dermatitis market are Velite Pharmaceuticals, Galderma SA, Pfizer Inc, Fujisawa Healthcare, Inc., Dow, Regeneron Pharmaceuticals, Inc, LEO Pharma A/S, Sanofi, Novartis AG, Bristol-Myers Squibb Company, Bayer AG, Meda Pharmaceuticals Inc., Connetics Corporation, ALLERGAN, and Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, F. Hoffmann-La Roche AG, Encore Dermatology, Inc., AbbVie Inc. and few among others.
Market Definition:
Atopic dermatitis can be defined as a chronic inflammatory skin condition that affects patients of all age group and is a result of a complex interplay of multiple factors including environmental, immunological, genetic, and pharmacologic factors.
According to the article published in National Center for Biotechnology Information 2018, It was estimated that totoal population of atopic dermatitis in the United States over 4.9% , in Canada 4.4% and 3.5% in Europe. The prevalent was higher in female as comapared to male. Increasing number of atopic dermatitis cases worldwide and accelerating demand of clinical treatment and novel therapies indicates the significant growth of market.
Market Drivers
Strong product pipeline for atopic dermatitis
Availability of novel drug therapies and generic alternatives
Increase in awareness of atopic dermatitis
Growing cases of atopic dermatitis worldwide
Market Restraints
Upcoming patent expiry of products of many companies
Allergic reactions of off-label therapies
Effective treatment is either unavailable or unaffordable
Global Atopic Dermatitis Market: Table Of Content
Part 01: Executive Summary
Part 02: Scope of The Report
Part 03: Global Atopic Dermatitis Market Landscape
Part 04: Global Atopic Dermatitis Market Sizing
Part 05: Global Atopic Dermatitis Market Segmentation By Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
View Detailed Table of Content @ https://www.databridgemarketresearch.com/toc/?dbmr=global-atopic-dermatitis-market
Segmentation: Global Atopic Dermatitis Market
By Mechanism of Action Type
Antihistamines
Topical corticosteroids
Emollients
Phosphodieterase-4 (PDE-4) inhibitor
Topical antiseptic
Others
By Mode of Administration
Injectable
Topical
Oral
By Drug Type
Triamcinolone
Clobetasol
Tacrolimus topical
Betamethasone
Pimecrolimus
Fluocinonide
Hydrocortisone
Prednisone
Crisaborole
Fluticasone
Methylprednisolone
Others
By End- User
Hospitals
Research Centers
Clinics
Home Care
By Distribution Channel
Mail Order Pharmacies
Hospital Pharmacies
Online Pharmacies
Drug Stores
Retail Pharmacies
Dermatology Clinics
By Geography
North America
South America
Europe
Asia-Pacific
Middle East & Africa
Key Developments in the Market:
In March 2017, Regeneron Pharmaceuticals, Inc. in a collaboration with Sanofi received the US FDA approval for Dupixent (dupilumab) injection for the treatment of moderate to severe atopic dermatitis (AD) in adult patient
In December 2016, Pfizer Inc. received the US FDA approval for Eucrisatm (crisaborole), a phosphodieterase-4 (PDE-4) inhibitor for the treatment of mild to moderate atopic dermatitis (AD) in padiatric patient as well as adult patient
Competitive Analysis:
Global atopic dermatitis market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of atopic dermatitis market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Buy Full Copy Global Atopic Dermatitis Market Report @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-atopic-dermatitis-market
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com
About Data Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Atopic Dermatitis Market Growing Demand by Top Key Players like Regeneron Pharmaceuticals, Inc, LEO Pharma A/S, Sanofi, Novartis AG, Bristol-Myers Squibb Company here
News-ID: 1848802 • Views: …
More Releases from Data Bridge Market Research
The Dental Needle Market: An Overview of Trends and Growth Factors 2028
The dental needle market plays a crucial role in the field of dentistry, serving as an essential tool for administering local anesthesia and performing various dental procedures. As dental practices continue to evolve, the demand for high-quality dental needles has increased, reflecting advancements in technology, patient care, and safety standards. This post explores the dental needle market's overview, scope, current trends, and the factors driving its growth.
The dental needle market…
Laser Capture Microdissection Market to Exhibit a Remarkable CAGR of 10.81% by 2 …
Global laser capture microdissection market size was valued at USD 184.57 million in 2023 and is projected to reach USD 419.56 million by 2031, with a CAGR of 10.81% during the forecast period of 2024 to 2031.
Market Definition:
Laser capture microdissection (LCM) is a technique used in molecular biology and pathology to isolate specific cells or tissues from a heterogeneous sample under microscopic visualization. It involves using a laser beam to…
Dental Digital X Ray Market to Exhibit a Remarkable CAGR of 4.5% by 2031, Size, …
Global dental digital X-Ray market size was valued at USD 3.31 billion in 2023 and is projected to reach USD 4.71 billion by 2031, with a CAGR of 4.5% during the forecast period of 2024 to 2031.
Market Definition:
Dental digital X-ray, also known as dental digital radiography, is a preventive and diagnostic technique in which X-rays travel through any soft tissue, such as the gums, and are absorbed by dense tissues,…
Companion Animal Vaccines Market to Exhibit a Remarkable CAGR of 5.60% by 2031, …
Global companion animal vaccines market size was valued at USD 3.35 billion in 2023 and is projected to reach USD 5.17 billion by 2031, with a CAGR of 5.60% during the forecast period of 2024 to 2031.
Market Definition:
Companion animals' vaccine are the vaccines that are given to the pets (dogs, cats and others) to stimulate their immune response. In other words, the companion animal vaccines are used to improve the…
More Releases for Atopic
Atopic Dermatitis - Drug Pipeline Landscape, 2022
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may cr*ck and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness.
Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger an…
Atopic Dermatitis (Atopic Eczema) Treatment Market Business Growth And Industry …
Precision Business Insights published a research report on “Atopic Dermatitis (Atopic Eczema) Treatment Market by Drug type (Corticosteroids, Calcineurin Inhibitors, Immunosuppressants, Phosphodiesterase type 4 (PDE-4) Inhibitors, Antibiotics, Antihistamines, Emollients), Route of administration (Oral, Topical, Parenteral), Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography - Global/Region/Country Forecast to 2027”.
In people who suffer from atopic dermatitis, allergies play a big influence. When the patient is exposed to…
Current research: Demand for Atopic Dermatitis Treatment Market rapidly growing …
Report Ocean released a report deciphering the Atopic Dermatitis Treatment Market report that provides in-depth analysis and crucial insights into key factors that are crucial to the success of the market.
The report is a systematic study of the market that provides key statistics on trends, analyst views, competitive landscapes, and key regions markets report is a comprehensive study. In this research report, key business trends and upcoming Atopic Dermatitis Treatment…
Atopic Dermatitis (Atopic Eczema) - Pipeline Review, H2 2018 - ResearchByMarkets …
"Atopic Dermatitis (Atopic Eczema) - Pipeline Review, H2 2018", provides an overview of the Atopic Dermatitis (Atopic Eczema) (Dermatology) pipeline landscape.
Atopic dermatitis is an itchy inflammation of skin. Signs and symptoms of atopic dermatitis include red to brownish-gray colored patches, itching, which may be severe, especially at night, small, raised bumps, which may leak fluid and crust over when scratched, thickened, cracked or scaly skin and raw, sensitive skin from…
Atopic Dermatitis - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Atopic Dermatitis - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atopic Dermatitis - Pipeline Review, H2 2017, provides an overview of the Atopic Dermatitis (Dermatology) pipeline landscape.
Atopic dermatitis is an itchy inflammation of skin. Signs and symptoms of atopic dermatitis include red to brownish-gray colored…
Global Atopic Dermatitis (Atopic Eczema) Treatment Market: Market Estimation, Dy …
Atopic dermatitis is also known as atopic eczema. Atopic dermatitis is a type of inflammatory disease which is of unknown origin usually starts in early infancy, but also affects a major number of adults. Atopic dermatitis results in itchy, red, swollen and cracked skin. Many people with atopic dermatitis may develop hay fever and asthma. The causes are unknown but it is found to involve inherited, immune system dysfunction, environmental…
